Publication: Antimicrobial use and resistance data in human and animal sectors in the Lao PDR: Evidence to inform policy
Issued Date
2021-12-01
Resource Type
ISSN
20597908
Other identifier(s)
2-s2.0-85121251918
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
BMJ Global Health. Vol.6, No.12 (2021)
Suggested Citation
Vilada Chansamouth, Mayfong Mayxay, David A.B. Dance, Tamalee Roberts, Rattanaxay Phetsouvanh, Bouakham Vannachone, Manivanh Vongsouvath, Viengmon Davong, Phout Inthavong, Syseng Khounsy, Bounxou Keohavong, Valy Keoluangkhot, Khamla Choumlivong, Nicholas P.J. Day, Paul Turner, Elizabeth A. Ashley, H. Rogier Van Doorn, Paul N. Newton Antimicrobial use and resistance data in human and animal sectors in the Lao PDR: Evidence to inform policy. BMJ Global Health. Vol.6, No.12 (2021). doi:10.1136/bmjgh-2021-007009 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/77462
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Antimicrobial use and resistance data in human and animal sectors in the Lao PDR: Evidence to inform policy
Author(s)
Vilada Chansamouth
Mayfong Mayxay
David A.B. Dance
Tamalee Roberts
Rattanaxay Phetsouvanh
Bouakham Vannachone
Manivanh Vongsouvath
Viengmon Davong
Phout Inthavong
Syseng Khounsy
Bounxou Keohavong
Valy Keoluangkhot
Khamla Choumlivong
Nicholas P.J. Day
Paul Turner
Elizabeth A. Ashley
H. Rogier Van Doorn
Paul N. Newton
Mayfong Mayxay
David A.B. Dance
Tamalee Roberts
Rattanaxay Phetsouvanh
Bouakham Vannachone
Manivanh Vongsouvath
Viengmon Davong
Phout Inthavong
Syseng Khounsy
Bounxou Keohavong
Valy Keoluangkhot
Khamla Choumlivong
Nicholas P.J. Day
Paul Turner
Elizabeth A. Ashley
H. Rogier Van Doorn
Paul N. Newton
Other Contributor(s)
Faculty of Tropical Medicine, Mahidol University
Oxford University Clinical Research Unit
Ministry of Health Laos
London School of Hygiene & Tropical Medicine
Mahosot Hospital, Lao
Nuffield Department of Medicine
Cambodia Oxford Medical Research Unit
University of Health Sciences
Ministry of Agriculture
Setthathirath Hospital
Oxford University Clinical Research Unit
Ministry of Health Laos
London School of Hygiene & Tropical Medicine
Mahosot Hospital, Lao
Nuffield Department of Medicine
Cambodia Oxford Medical Research Unit
University of Health Sciences
Ministry of Agriculture
Setthathirath Hospital
Abstract
Objectives To review the scientific evidence base on antimicrobial use (AMU) and antimicrobial resistance (AMR) in human and animal sectors in the Lao PDR (Laos). Methods We reviewed all publications from July 1994 (the first article describing AMR in Laos) to December 2020. Electronic searches were conducted using Google Scholar and PubMed with specific terms relating to AMR and AMU in Lao, French and English languages. Findings We screened 1,357 peer-reviewed and grey reports by title and abstract and then full articles/reports. Of 80 included, 66 (83%) related to human health, nine (11%) to animal health, four (5%) to both animal and human health and one (1%) to the environment. Sixty-two (78%) were on AMR and 18 (22%) on AMU. Extended spectrum beta lactamase-producing Escherichia coli was the greatest concern identified; the proportion of isolates increased fivefold from 2004 to 2016 (2/28 (7%) to 27/78 (35%)) from blood cultures submitted to the Microbiology Laboratory, Mahosot Hospital, Vientiane. Carbapenem resistant Escherichia coli was first identified in 2015. Methicillin-resistant Staphylococcus aureus (MRSA) was uncommon, with 15 cases of MRSA from blood cultures between its first identification in 2017 and December 2020. AMR patterns of global antimicrobial resistance surveillance system (GLASS) target pathogens from livestock were less well documented. There were few data on AMU in human health and none on AMU in livestock. The first hospital AMU survey in Laos showed that 70% (1,386/1,981) of in-patients in five hospitals from 2017 to 2018 received antimicrobial(s). Antibiotic self-medication was common. Conclusion AMR in Laos is occurring at relatively low proportions for some GLASS pathogens, giving the country a window of opportunity to act quickly to implement strategies to protect the population from a worsening situation. Urgent interventions to roll out new guidelines with enhanced one-health antibiotic stewardship, reduce antibiotic use without prescriptions, enhance surveillance and improve understanding of AMU and AMR are needed.